Full name
BOBER-PHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
20.4 - Manufacture of cleaning, washing, and cleaning products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
68.20.Z - Rental and management of own or leased real estate
73.11.Z - Advertising agency activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,1 | 1 | 1,3 | 24,3 |
EBITDA | 1,1 | 1,1 | 1,4 | 24,6 |
Short time liabilities | 0,3 | 0,8 | 0,8 | -1,9 |
Equity capital | 2,5 | 2,6 | 2,9 | 11,3 |
Operating profit (EBIT) | 1,1 | 1 | 1,3 | 24,2 |
Assets | 3 | 3,6 | 3,8 | 7,6 |
Net profit (loss) | 0,9 | 0,8 | 1 | 24,8 |
Cash | 0,9 | 1,2 | 1,1 | -5,8 |
Net income from sale | 12,2 | 13,7 | 15,3 | 11,4 |
Liabilities and provisions for liabilities | 0,5 | 1 | 1 | -2,1 |
Working assets | 2,8 | 3,4 | 3,7 | 9,3 |
Depreciation | 0,1 | 0,1 | 0,1 | 30,1 |
% | % | % | p.p. | |
Profitability of capital | 36,7 | 32,2 | 36,1 | 3,9 |
Equity capital to total assets | 82,5 | 72,3 | 74,7 | 2,4 |
Gross profit margin | 8,9 | 7,5 | 8,4 | 0,9 |
EBITDA Margin | 9,4 | 7,9 | 8,9 | 1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 10 | 21 | 19 | -2 |
Current financial liquidity indicator | 5.36016845703125 | 3.4667017459869385 | 3.870210647583008 | 0,4 |
Net dept to EBITDA | -0.7436250448226929 | -1.0938800573349 | -0.8268190026283264 | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane